Joyce Hays, CEO

Ms. Joyce Hays is CEO and founder of Target Health Inc., a New York City based CRO with expertise in Regulatory Affairs, including FDA interactions and all submissions, Strategic Planning, Clinical Research Management, Biostatistics and Data Management, Medical Writing, Good Manufacturing Practices (GMP) and other support services to the pharmaceutical industry. Ms. Hays' responsibilities include corporate strategic planning, financial management, marketing and human resources. Previous executive experience includes co-founder and CFO of MarSat Development Corporation (Consumer Products) and CFO of Dobex International (Gas and Oil Research). Ms. Hays founded the Institute for Interdisciplinary Communication, a scientific think tank which received funding from the National Science Foundation. Ms. Hays earned B.S. and M.S. degrees from Columbia University in New York City.

Dr. Jules Mitchel, President

Dr. Jules T. Mitchel is President of Target Health Inc., a New York City based CRO with expertise in Regulatory Affairs, including FDA interactions and all submissions, Strategic Planning, Clinical Research Management, Biostatistics and Data Management, Medical Writing, Good Manufacturing Practices (GMP) and other support services to the pharmaceutical industry. Dr. Mitchel has broad base pharmaceutical experience in drugs, biologics, devices and diagnostics including three NDA submission, many FDA meetings and IND/IDE submissions, study reports, manuscripts and strategic planning. Areas of expertise include but are not limited to, Women's Health, Dermatology, Antimicrobials, Pharmacokinetics, Rheumatology, Ophthalmology, Natural Products, Oral Care, Oncology and Regulatory Affairs. Dr. Mitchel has held industry positions at American Home Products, Pfizer Laboratories and Pfizer Consumer Health Care and academic positions at New York Medical College, Cornell University School of Medicine and NYU School of Medicine.